Lack of ethnic differences in the pharmacokinetics and pharmacodynamics of evolocumab between Caucasian and Asian populations
Author:
Affiliation:
1. Amgen Asia R&D Center Zhangjiang High‐Tech Park Shanghai China
2. Center for Drug Clinical ResearchShanghai University of Traditional Chinese Medicine Zhangjiang High‐Tech Park Shanghai China
Funder
Shanghai Pudong New District Technology Development Postdoctoral Fund
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13767
Reference30 articles.
1. Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia
2. Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
3. Evolocumab: A Review in Hyperlipidemia
4. Theoretical considerations of what regulates low-density-lipoprotein and high-density-lipoprotein cholesterol
5. Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart Disease
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Population pharmacokinetic and pharmacokinetic-pharmacodynamic modeling of bempedoic acid and low-density lipoprotein cholesterol in healthy subjects and patients with dyslipidemia;Journal of Pharmacokinetics and Pharmacodynamics;2023-05-27
2. Prenatal Diagnosis: The Main Advances in the Application of Identification of Biomarkers Based on Multi-Omics;Ectopic Pregnancy and Prenatal Diagnosis;2022-12-07
3. Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan;Journal of Atherosclerosis and Thrombosis;2022
4. Real-world data on the prescription of proprotein convertase subtilisin/kexin type 9 inhibitors in high-risk patients in a tertiary medical center;Journal of the Formosan Medical Association;2021-11
5. Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory Antibodies;Journal of the American College of Cardiology;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3